U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Wewoka Animal Hospital - 577595 - 06/24/2021
  1. Warning Letters

CLOSEOUT LETTER

Wewoka Animal Hospital MARCS-CMS 577595 —

Delivery Method:
UPS Overnight
Product:
Animal & Veterinary
Recipient:
Recipient Name
Dr. Rory G. Stricklin
Wewoka Animal Hospital
Robie Watters

12821 Ns 3650
Wewoka, OK 74884
United States

Issuing Office:
Division of Human and Animal Food Operations West III

United States

Secondary Issuing Offices

United States

Dear Dr. Rory G. Stricklin:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter (CMS #577595, dated June 3, 2019) issued following an inspection of your Wewonka Animal Hospital located at 12821 Ns 3650, Wewoka, Oklahoma 74884. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Sincerely,
/S/
Jessica E. Havranek
Director, Compliance Branch
Human & Animal Food Operations, WD3

Back to Top